<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Dr. Nicole Wagner Archive - SpaceWatch.GLOBAL</title>
	<atom:link href="https://spacewatch.global/tag/dr-nicole-wagner/feed/" rel="self" type="application/rss+xml" />
	<link>https://spacewatch.global/tag/dr-nicole-wagner/</link>
	<description>AN INDEPENDENT PERSPECTIVE ON SPACE</description>
	<lastBuildDate>Fri, 18 Aug 2023 08:00:30 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://spacewatch.global/wp-content/uploads/2024/09/SpaceWatchGlobal-Sign-90x90.png</url>
	<title>Dr. Nicole Wagner Archive - SpaceWatch.GLOBAL</title>
	<link>https://spacewatch.global/tag/dr-nicole-wagner/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>#SpaceWatchGL Summer Reading: The Wonders of Micro-G Medicine 4</title>
		<link>https://spacewatch.global/2023/08/spacewatchglobal-summer-reading-the-wonders-of-micro-g-medicine-4/</link>
		
		<dc:creator><![CDATA[Louise Weightman]]></dc:creator>
		<pubDate>Fri, 18 Aug 2023 08:00:30 +0000</pubDate>
				<category><![CDATA[Features]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[SpaceWatch.Global Opinion]]></category>
		<category><![CDATA[CubeLab]]></category>
		<category><![CDATA[Dr. Nicole Wagner]]></category>
		<category><![CDATA[Dr. Robert Birge]]></category>
		<category><![CDATA[ISS]]></category>
		<category><![CDATA[LambdaVision]]></category>
		<category><![CDATA[MassChallenge]]></category>
		<category><![CDATA[micro-g]]></category>
		<category><![CDATA[National Science Foundation]]></category>
		<category><![CDATA[SpaceTango CubeLabs]]></category>
		<category><![CDATA[SpaceX]]></category>
		<category><![CDATA[University of Connecticut]]></category>
		<guid isPermaLink="false">https://spacewatch.global/?p=50578</guid>

					<description><![CDATA[<a href="https://spacewatch.global/2023/08/spacewatchglobal-summer-reading-the-wonders-of-micro-g-medicine-4/" title="#SpaceWatchGL Summer Reading: The Wonders of Micro-G Medicine 4" rel="nofollow"><img width="558" height="400" src="https://spacewatch.global/wp-content/uploads/2023/08/MICRO_G_PART_4_PIC_4_08_edited-1.jpeg" class="webfeedsFeaturedVisual wp-post-image" alt="SpaceX Crew-4 200-layer thin film as seen at 100 micrometer resolution under an electronic microscope. Credit: LambdaVision" style="display: block; margin-bottom: 5px; clear:both;max-width: 100%;" link_thumbnail="1" decoding="async" srcset="https://spacewatch.global/wp-content/uploads/2023/08/MICRO_G_PART_4_PIC_4_08_edited-1.jpeg 737w, https://spacewatch.global/wp-content/uploads/2023/08/MICRO_G_PART_4_PIC_4_08_edited-1-300x215.jpeg 300w" sizes="(max-width: 558px) 100vw, 558px" /></a>As reviewed in Part 3, LambdaVision, based in Farmington, Connecticut, USA, was founded in 2009 by its President and CEO Dr. Nicole Wagner and co-founder chemist Jordan Greco. Dr. Robert Birge, distinguished chair in chemistry at the University of Connecticut, a renowned expert in the incorporation of light-activated proteins into biomolecular electronic and therapeutic applications, is a Member of the Board of Directors of the company.]]></description>
		
		
		
			</item>
		<item>
		<title>#SpaceWatchGL Summer Reading: The Wonders of Micro-G Medicine 3</title>
		<link>https://spacewatch.global/2023/08/spacewatchgl-summer-reading-the-wonders-of-micro-g-medicine-3/</link>
		
		<dc:creator><![CDATA[Louise Weightman]]></dc:creator>
		<pubDate>Fri, 11 Aug 2023 08:00:29 +0000</pubDate>
				<category><![CDATA[Features]]></category>
		<category><![CDATA[Frontiers News]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[SpaceWatch.Global Opinion]]></category>
		<category><![CDATA[Age-relate macular degeneration (AMD)]]></category>
		<category><![CDATA[bacteriorhodopsin]]></category>
		<category><![CDATA[Dr. Jordan Greco]]></category>
		<category><![CDATA[Dr. Nicole Wagner]]></category>
		<category><![CDATA[Dr. Robert Birge]]></category>
		<category><![CDATA[LambdaVision]]></category>
		<category><![CDATA[RIKEN]]></category>
		<category><![CDATA[University of Connecticut]]></category>
		<guid isPermaLink="false">https://spacewatch.global/?p=50451</guid>

					<description><![CDATA[<a href="https://spacewatch.global/2023/08/spacewatchgl-summer-reading-the-wonders-of-micro-g-medicine-3/" title="#SpaceWatchGL Summer Reading: The Wonders of Micro-G Medicine 3" rel="nofollow"><img width="800" height="362" src="https://spacewatch.global/wp-content/uploads/2023/08/MICRO_G_PART_3_PIC_3_03_HALOBACTERIA_LAKE_NAMIBIA_SWGL_CHRIS_-1.png" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin-bottom: 5px; clear:both;max-width: 100%;" link_thumbnail="1" decoding="async" srcset="https://spacewatch.global/wp-content/uploads/2023/08/MICRO_G_PART_3_PIC_3_03_HALOBACTERIA_LAKE_NAMIBIA_SWGL_CHRIS_-1.png 1758w, https://spacewatch.global/wp-content/uploads/2023/08/MICRO_G_PART_3_PIC_3_03_HALOBACTERIA_LAKE_NAMIBIA_SWGL_CHRIS_-1-300x136.png 300w, https://spacewatch.global/wp-content/uploads/2023/08/MICRO_G_PART_3_PIC_3_03_HALOBACTERIA_LAKE_NAMIBIA_SWGL_CHRIS_-1-1024x464.png 1024w, https://spacewatch.global/wp-content/uploads/2023/08/MICRO_G_PART_3_PIC_3_03_HALOBACTERIA_LAKE_NAMIBIA_SWGL_CHRIS_-1-768x348.png 768w, https://spacewatch.global/wp-content/uploads/2023/08/MICRO_G_PART_3_PIC_3_03_HALOBACTERIA_LAKE_NAMIBIA_SWGL_CHRIS_-1-1536x695.png 1536w" sizes="(max-width: 800px) 100vw, 800px" /></a>Blindness due to retina diseases affects over 200 million people globally, and that number is expected to reach 290 million by 2040. The two most common retina degenerative diseases are called Retinitis Pigmentosa and Age-related Macular Degeneration (AMD). Retinitis Pigmentosa affects one and a half million people globally. It starts with peripheral vision that goes dark, until the person is completely blind. AMD affects in the US alone 30 million people over 55, including 10 million in the blinding stage. AMD starts with central vision that goes dark, until the person is totally blind.]]></description>
		
		
		
			</item>
	</channel>
</rss>
